Retinoblastoma protein expression and MIB‐1 correlate with survival of patients with malignant astrocytoma

作者: Mitsutoshi Nakamura , Noboru Konishi , Shigeru Tsunoda , Yoshio Hiasa , Toshihide Tsuzuki

DOI: 10.1002/(SICI)1097-0142(19970715)80:2<242::AID-CNCR12>3.0.CO;2-U

关键词:

摘要: BACKGROUND Regulatory coupling of cell proliferation and apoptosis is suggested by recent findings with regard to certain tumors, such as the finding tumor resistance anticancer therapy caused inhibition apoptosis. The processes leading appear be regulated a variety oncogenes suppressor genes. In current study, relation between expression retinoblastoma protein (pRB) was assessed in 50 primary anaplastic astrocytomas (AAs) 46 recurrent tumors same patients after macroscopic total surgical resection chemoradiotherapy. METHODS Apoptotic cells were identified situ 3'-end labeling technique. Proliferative potential, pRB expression, p53 evaluated immunohistochemically using anti-Ki-67 (MIB-1), anti-pRB, anti-p53 antibodies, respectively. prognostic value these biologic markers AA undergoing treatment also evaluated. RESULTS The mean apoptotic index (AI) 0.91 ± 0.70% for specimens obtained at initial surgery 2.32 1.71% those recurrence. There no apparent correlation AI MIB-1 staining (MI) AAs, whereas significantly higher MI observed negative cases than their positive counterparts. survival AAs showing high immunostaining shorter other cases. Neither size fraction nor correlated overall survival. CONCLUSIONS The clinical outcome may associated aberrant function increased proliferative activity rather an inability undergo Cancer 1997; 80:242-9. © 1997 American Society.

参考文章(48)
Mitsutoshi Nakamura, Noboru Konishi, Shigeru Tsunoda, Yoshio Hiasa, Toshihide Tsuzuki, Hideo Aoki, Kunihiko Kobitsu, Hisaki Nagai, Toshisuke Sakaki, Analyses of human gliomas by restriction landmark genomic scanning. Journal of Neuro-oncology. ,vol. 35, pp. 113- 120 ,(1997) , 10.1023/A:1005712308061
D.A. Haas-Kogan, S.C. Kogan, D. Levi, P. Dazin, A. T'Ang, Y.K. Fung, M.A. Israel, Inhibition of apoptosis by the retinoblastoma gene product. The EMBO Journal. ,vol. 14, pp. 461- 472 ,(1995) , 10.1002/J.1460-2075.1995.TB07022.X
Robyn L. Castleberg, Griffith R. Harsh, John W. Henson, David N. Louis, Lloyd M. Alderson, Human Gliomas with Wild-Type p53 Express bcl-2 Cancer Research. ,vol. 55, pp. 999- 1001 ,(1995)
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Michael J. Winger, David R. Macdonald, J. Gregory Cairncross, Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. Journal of Neurosurgery. ,vol. 71, pp. 487- 493 ,(1989) , 10.3171/JNS.1989.71.4.0487
Hong Ji Xu, William F. Benedict, Shi Xue Hu, Philip T. Cagle, Jian Li, Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis. Clinical Cancer Research. ,vol. 2, pp. 1169- 1176 ,(1996)
Jane B. Trepel, Erasmus Schneider, Charles E. Myers, Markus M. Borner, Yoshitatsu Sei, Oliver Sartor, Toshiyuki Toko, Drug-induced Apoptosis Is Not Necessarily Dependent on Macromolecular Synthesis or Proliferation in the p53-negative Human Prostate Cancer Cell Line PC-3 Cancer Research. ,vol. 55, pp. 2122- 2128 ,(1995)
Setsuo Hirohashi, Takao Sekiya, Richard Sachse, Yoshinori Murakami, Hong Ji Xu, Xue Zhang, William F. Benedict, Shi Xue Hu, Kazuo Yashima, Deletions of Chromosome 13q, Mutations in Retinoblastoma 1, and Retinoblastoma Protein State in Human Hepatocellular Carcinoma Cancer Research. ,vol. 54, pp. 4177- 4182 ,(1994)
Christina Isacson, Kathleen R. Cho, Theodore D. Kessis, Lora Hedrick, Both Cell Proliferation and Apoptosis Increase with Lesion Grade in Cervical Neoplasia but Do Not Correlate with Human Papillomavirus Type Cancer Research. ,vol. 56, pp. 669- 674 ,(1996)